“…Co-encapsulation of drugs in nanocarriers constitutes a promising approach for tumor drug delivery of fixed drug ratios aiming at achieving higher efficacy and reduced side effects [1,2]. Materials and methods: In vitro quantitative evaluation of combinations with conventional and innovative drugs, at different ratios and in free or nano-encapsulated form, was performed and cytotoxicity assessed by the resazurin assay [3]. Determination of synergism, additivity or antagonism, against the HRPC PC-3 cell line, was performed by the median effect analysis [4].…”